Diuretic drugs benefit patients with hypertension more with night-time dosing

Author:

Okeahialam Basil N1,Ohihoin Esther N2,Ajuluchukwu Jayne NA3

Affiliation:

1. Department of Medicine, Jos University Teaching Hospital, Jos, Plateau State 930001, Nigeria

2. Department of Medicine, General Hospital, Lagos, Nigeria

3. Department of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria

Abstract

Objectives: Night-time chronotherapy in antihypertensive drugs has been shown to produce better blood pressure control and protect from cardiovascular morbidity and mortality. To date, this has been proven for several drug classes excluding thiazides diuretics. Given the peculiar response of blood pressure to thiazides in black people we sought to determine whether night-time chronotherapy with thiazides produces better control as already shown with other drug classes. Methods: A subanalysis of a larger chronotherapy study with antihypertensive drugs in Nigerian Africans was done. The subpopulation of those whose disease was controlled after 12 weeks of diuretic monotherapy was analysed. Those who received drugs in the morning and at night were compared along control lines and some cardiac indices. Results: Both groups were similar on all scores at baseline. After 12 weeks of monotherapy patients who received drugs at night had significantly lower systolic and diastolic blood pressure though control was achieved with both morning and night-time dosing. Also the left ventricular posterior and septal walls regressed better as well as left ventricular mass in the night-time group. Conclusion: Though equally effective in reducing blood pressure and cardiac indices related to hypertension, patients taking their drugs at night recorded better values. This makes diuretics equally amenable to night-time chronotherapy as other drug classes. This effect should be explored to reduce the morbidity and mortality consequences of hypertension.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3